You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 42 No. 12, December 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Serotoninergic System in Dementia of the Alzheimer Type

Abnormal Forms of 5-Hydroxytryptophan and Serotonin in Cerebrospinal Fluid

Ladislav Volicer, MD, PhD; Philip J. Langlais, PhD; Wayne R. Matson, PhD; Konrad A. Mark, MD; Paul H. Gamache, MA

Arch Neurol. 1985;42(12):1158-1161.


Abstract

• Serotonin (5-HT), its precursor 5-hydroxytryptophan (5-HTP), and its major metabolite 5-hydroxyindoleacetic acid (5-HIAA) were measured in the cerebrospinal fluid (CSF) of 14 patients with dementia of the Alzheimer type (DAT) and in nine controls by high-performance liquid chromatography with a novel multisensor coulometric detection system. Concentrations of both 5-HT and 5-HIAA detected by this system were lower than the concentrations obtained using conventional amperometric detection. This difference was caused by coelution of compounds that could be resolved from 5-HT and 5-HIAA by the multisensor coulometric system. One of the coelution compounds, observed in DAT but not in control CSF, behaved like a partially oxidized 5-HT. A compound behaving like partially oxidized 5-HTP was also observed in DAT CSF. Concentrations of 5-HTP, 5-HT, and 5-HIAA were lower in DAT CSF than in a corresponding fraction of control CSF. These results indicate involvement of the serotoninergic system in DAT and might lead to development of a diagnostic test for DAT.



Author Affiliations

From the Geriatric Research Education Clinical Center, E. N. Rogers Veterans Memorial Hospital (Drs Volicer and Mark) and Environmental Science Associates, Inc (Dr Matson and Mr Gamache), Bedford, Mass; and McLean Hospital (Dr Langlais), Belmont, Mass.


Footnotes

Accepted for publication March 18, 1985.

Reprint requests to E. N. Rogers Memorial Veterans Hospital, GRECC, 200 Springs Rd, Bedford, MA 01730 (Dr Volicer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Brain Gangliosides in Dementia of the Alzheimer Type
Crino et al.
Arch Neurol 1989;46:398-401.
ABSTRACT  

L-Deprenyl in Alzheimer's Disease: Preliminary Evidence for Behavioral Change With Monoamine Oxidase B Inhibition
Tariot et al.
Arch Gen Psychiatry 1987;44:427-433.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.